Nova Biomedical Taps Diabetes Market

Published: Oct 05, 2012

Boston Business Journal by Julie M. Donnelly,

Waltham-based Nova Biomedical is quietly becoming a major force in the local medical device industry, cracking $200 million in revenue this fiscal year and approaching 1,000 workers, on the growth of the diabetes epidemic.

The medical device firm began as a maker of blood gas analyzer devices, used in the critical care and emergency room settings to test patients’ blood, and that segment is still Nova’s largest business. But now the fastest-growing segment is its point-of-care glucose meters for the hospital setting, which are used for diabetes patients and for others, such as trauma patients, who may experience a spike ...

Back to news